Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 7
2004 6
2005 6
2006 8
2007 10
2008 9
2009 17
2010 16
2011 18
2012 24
2013 16
2014 26
2015 20
2016 29
2017 47
2018 40
2019 25
2020 35
2021 33
2022 25
2023 32
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Nishida Y, Kano K, Nobuoka Y, Seo T. Nishida Y, et al. Arthritis Rheumatol. 2021 Nov;73(11):2148-2149. doi: 10.1002/art.41786. Epub 2021 Sep 22. Arthritis Rheumatol. 2021. PMID: 33982897 Free PMC article. No abstract available.
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, Harada N, Miyahara Y, Seo N, Hattori H, Takada K, Emori M, Kakunaga S, Endo M, Matsumoto Y, Sasada T, Sato E, Yamada T, Matsumine A, Nagata Y, Watanabe T, Kageyama S, Shiku H. Ishihara M, et al. Among authors: nishida y. Int J Cancer. 2023 Jun 15;152(12):2554-2566. doi: 10.1002/ijc.34453. Epub 2023 Feb 17. Int J Cancer. 2023. PMID: 36727538 Clinical Trial.
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.
Cortes-Ciriano I, Steele CD, Piculell K, Al-Ibraheemi A, Eulo V, Bui MM, Chatzipli A, Dickson BC, Borcherding DC, Feber A, Galor A, Hart J, Jones KB, Jordan JT, Kim RH, Lindsay D, Miller C, Nishida Y, Proszek PZ, Serrano J, Sundby RT, Szymanski JJ, Ullrich NJ, Viskochil D, Wang X, Snuderl M, Park PJ, Flanagan AM, Hirbe AC, Pillay N, Miller DT; Genomics of MPNST (GeM) Consortium. Cortes-Ciriano I, et al. Among authors: nishida y. Cancer Discov. 2023 Mar 1;13(3):654-671. doi: 10.1158/2159-8290.CD-22-0786. Cancer Discov. 2023. PMID: 36598417 Free PMC article.
The current management of clear cell sarcoma.
Ikuta K, Nishida Y, Imagama S, Tanaka K, Ozaki T. Ikuta K, et al. Among authors: nishida y. Jpn J Clin Oncol. 2023 Oct 4;53(10):899-904. doi: 10.1093/jjco/hyad083. Jpn J Clin Oncol. 2023. PMID: 37451697 Review.
Roles of hyaluronan in cardiovascular and nervous system disorders.
Ding HY, Xie YN, Dong Q, Kimata K, Nishida Y, Ishiguro N, Zhuo LS. Ding HY, et al. Among authors: nishida y. J Zhejiang Univ Sci B. 2019 May;20(5):428-436. doi: 10.1631/jzus.B1900155. J Zhejiang Univ Sci B. 2019. PMID: 31090268 Free PMC article. Review.
TGF-β signaling promotes desmoid tumor formation via CSRP2 upregulation.
Li Y, Fujishita T, Mishiro-Sato E, Kojima Y, Niu Y, Taketo MM, Urano Y, Sakai T, Enomoto A, Nishida Y, Aoki M. Li Y, et al. Among authors: nishida y. Cancer Sci. 2024 Feb;115(2):401-411. doi: 10.1111/cas.16037. Epub 2023 Dec 1. Cancer Sci. 2024. PMID: 38041233 Free PMC article.
Targetable driver mutations in multicentric reticulohistiocytosis.
Murakami N, Sakai T, Arai E, Muramatsu H, Ichikawa D, Asai S, Shimoyama Y, Ishiguro N, Takahashi Y, Okuno Y, Nishida Y. Murakami N, et al. Among authors: nishida y. Haematologica. 2020 Jan 31;105(2):e61-e64. doi: 10.3324/haematol.2019.218735. Print 2020. Haematologica. 2020. PMID: 31171640 Free PMC article. No abstract available.
391 results